Description

Fast antigen detection for early identification of active COVID-19 infection

The BIOBASE SARS-CoV-2 Antigen Test Kit uses colloidal-gold immunochromatography to rapidly identify viral antigen proteins from nasopharyngeal or nasal swab samples. Designed for early-phase infection detection, the kit provides results within 15 minutes with high sensitivity and specificity. Its straightforward sample-processing workflow reduces operator time, while single-use extraction tubes and prefilled buffer solutions support safe specimen handling. The kit is suitable for outpatient clinics, emergency rooms, institutional screening and point-of-care diagnostic stations requiring quick detection of active infections.

Key Features & Technical Highlights:
• 15-minute antigen detection — accelerates identification of active COVID-19 cases
• Suitable for early infection windows — improves clinical triage effectiveness
• Simple sample collection with minimal steps — reduces operator error
• High sensitivity and specificity — supports reliable frontline diagnostics
• Individually packaged test components — provide safe, sterile single-use workflow

Workflow & Clinical Use:
The test enables rapid triage and early detection of contagious individuals, supporting infection-control workflows in hospitals, workplaces and community screening programs.